Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Welcome to VJOncology - an independent, open-access video journal delivering the latest news, insights and education in oncology.

Explore expert interviews from international congresses, dive into disease-specific content, and stay informed on practice-changing advances.

Genitourinary Cancer
Lung Cancer
Breast Cancer
Head and Neck
Gastrointestinal Cancer
Skin Cancer
Gynecological Cancer
Sarcoma
Watch our advances in GI cancer highlights webinar
Watch our advances in GI cancer highlights webinar
The VJ Sessions
The VJ Sessions

Expert-led roundtable discussions covering the latest advances and hot topics in oncology
Advances in Lung Cancer
Advances in Lung Cancer

Catch up on our Advances in Lung Cancer highlights Webinar. Featuring presentations & expert discussions on the latest breakthroughs and clinical developments in lung cancer
Breast Cancer Session
Breast Cancer Session

Breast Cancer Session with Kevin Kalinsky and Komal Jhaveri on ground-breaking trials at ASCO 2025
CACA 2025
CACA 2025

VJOncology had the pleasure to collaborate with TalkMed, who covered the 2025 China Anti-Cancer Association (CACA) Conference, held November 6–9, 2025, in Kunming, China
Currently Trending
Watch Tom Newsom-Davis discuss NSCLC with EGFR exon 20 insertions at WCLC 2026: PAPILLON & REZILIENT 3 3:41
NSCLC with EGFR exon 20 insertions at WCLC 2026: PAPILLON & REZILIENT 3
Tom Newsom-Davis • 14 Sep 2026
Watch Wungki Park discuss POLAR: pembrolizumab and olaparib in HRD metastatic pancreatic cancer 2:17
POLAR: pembrolizumab and olaparib in HRD metastatic pancreatic cancer
Wungki Park • 2 Jul 2026
Watch Giulia Martini discuss Can ctDNA guide cetuximab sequencing and re-challenge strategies in MSS mCRC? 0:44
Can ctDNA guide cetuximab sequencing and re-challenge strategies in MSS mCRC?
Giulia Martini • 2 Jul 2026
Watch Dean Fennell discuss MIST3: bemcentinib and pembrolizumab in relapsed mesothelioma 1:13
MIST3: bemcentinib and pembrolizumab in relapsed mesothelioma
Dean Fennell • 13 Sep 2026
Lung-Wide-Banner copy GI-Wide-Banner-copy Sept 2026
View Latest Videos by Disease
Watch the latest videos from the Genitourinary Cancer Channel
Genitourinary Cancer
Watch the latest videos from the Lung Cancer Channel
Lung Cancer
Watch the latest videos from the Head and Neck Cancer Channel
Head and Neck Cancer
Watch the latest videos from the Breast Cancer Channel
Breast Cancer
Watch the latest videos from the Gastrointestinal Cancer Channel
Gastrointestinal Cancer
Watch the latest videos from the Gynecological Cancer Channel
Gynecological Cancer
Watch the latest videos from the Skin Cancer Channel
Skin Cancer
Watch the latest videos from the Sarcoma Channel
Sarcoma
View all diseases
View more content
Trials
Medicines
Conferences
Features
The content of VJOncology is intended for healthcare professionals